Characterization of Vaccine Breakthrough Cases during Measles Outbreaks in Milan and Surrounding Areas, Italy, 2017-2021
- PMID: 35632809
- PMCID: PMC9147195
- DOI: 10.3390/v14051068
Characterization of Vaccine Breakthrough Cases during Measles Outbreaks in Milan and Surrounding Areas, Italy, 2017-2021
Abstract
Despite the existence of an effective live-attenuated vaccine, measles can appear in vaccinated individuals. We investigated breakthrough measles cases identified during our surveillance activities within the measles/rubella surveillance network (MoRoNet) in Milan and surrounding areas (Northern Italy). Between 2017 and 2021, we confirmed measles virus (genotypes B3 or D8) infections in 653 patients and 51 of these (7.8%) were vaccinees. Among vaccinated individuals whose serum was available, a secondary failure was evidenced in 69.4% (25/36) of cases while 11 patients (30.6%) were non-responders. Non-responders were more frequently hospitalized and had significantly lower Ct values in both respiratory and urine samples. Median age and time since the last immunization were similar in the two groups. Importantly, we identified onward transmissions from vaccine failure cases. Vaccinees were involved in 20 outbreaks, in 10 of them they were able to transmit the virus, and in 8 of them, they were the index case. Comparing viral hemagglutinin sequences from vaccinated and non-vaccinated subjects did not show a specific mutation pattern. These results suggest that vaccination failure was likely due to the poor immune response of single individuals and highlights the importance of identifying breakthrough cases and characterizing their clinical and virologic profiles.
Keywords: hemagglutinin; measles vaccine; measles virus; vaccination failure.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Increased reports of measles in the Metropolitan City of Milan, northern Italy, September 2023 to March 2024.Euro Surveill. 2024 Apr;29(16):2400201. doi: 10.2807/1560-7917.ES.2024.29.16.2400201. Euro Surveill. 2024. PMID: 38639092 Free PMC article.
-
Surveillance and vaccination coverage of measles and rubella in Northern Italy.Hum Vaccin Immunother. 2015;11(1):206-13. doi: 10.4161/hv.35865. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483537 Free PMC article.
-
Genetic characterisation of Measles virus variants identified during a large epidemic in Milan, Italy, March-December 2017.Epidemiol Infect. 2019 Jan;147:e80. doi: 10.1017/S0950268818003606. Epidemiol Infect. 2019. PMID: 30869017 Free PMC article.
-
Spotlight on measles in Italy: why outbreaks of a vaccine-preventable infection continue in the 21st century.Expert Rev Anti Infect Ther. 2015 Mar;13(3):355-62. doi: 10.1586/14787210.2015.1003808. Epub 2015 Jan 22. Expert Rev Anti Infect Ther. 2015. PMID: 25612664 Review.
-
Current status of measles in Japan.J Infect Chemother. 2003 Mar;9(1):1-7. doi: 10.1007/s10156-002-0206-6. J Infect Chemother. 2003. PMID: 12673398 Review.
Cited by
-
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Postelimination Era, 2001-2022.Clin Infect Dis. 2025 Mar 17;80(3):663-672. doi: 10.1093/cid/ciae470. Clin Infect Dis. 2025. PMID: 39271123
-
Impact of measles vaccination on clinical characteristics and outcomes in children in Ramadi, Iraq.World J Clin Pediatr. 2025 Sep 9;14(3):107253. doi: 10.5409/wjcp.v14.i3.107253. eCollection 2025 Sep 9. World J Clin Pediatr. 2025. PMID: 40881081
-
Breakthrough Infections: A Challenge towards Measles Elimination?Microorganisms. 2022 Aug 4;10(8):1567. doi: 10.3390/microorganisms10081567. Microorganisms. 2022. PMID: 36013985 Free PMC article. Review.
-
Adapting response to a measles outbreak in a context of high vaccination and breakthrough cases: an example from Vaud, Switzerland, January to March 2024.Euro Surveill. 2024 May;29(22):2400275. doi: 10.2807/1560-7917.ES.2024.29.22.2400275. Euro Surveill. 2024. PMID: 38818746 Free PMC article.
-
Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017-2022.Virol J. 2023 Jul 20;20(1):160. doi: 10.1186/s12985-023-02117-9. Virol J. 2023. PMID: 37474969 Free PMC article.
References
-
- World Health Organization Newsroom. Fatcts in Pictures. Detail. Measles. [(accessed on 26 January 2022)]. Available online: https://www.who.int/news-room/facts-in-pictures/detail/measles.
-
- World Health Organization Measles and Rubella Strategic Framework: 2021–2030. [(accessed on 4 January 2022)]. Available online: https://www.who.int/publications-detail-redirect/measles-and-rubella-str....
-
- Filia A., Bella A., Del Manso M., Rota M.C. Who Is at Risk for Measles in Italy? Continued Measles Outbreaks in 2019 and Barriers to Elimination. Int. J. Infect. Dis. 2020;101:354. doi: 10.1016/j.ijid.2020.09.929. - DOI
-
- Istituto Superiore di Sanità EpiCentro. Copertura Vaccinale in Italia. [(accessed on 4 January 2022)]. Available online: https://www.epicentro.iss.it/vaccini/dati_Ita.